RAVENQUEST BIOMED INC. Inactive Instrument
RavenQuest BioMed Inc. Stock Canadian Securities Exchange
Equities
RQB
CA7543871080
Business Support Services
| Sales 2017 | 0.11 0.15 | Sales 2018 | 1.26 1.72 | Capitalization | 58.71M 80.34M |
|---|---|---|---|---|---|
| Net income 2017 | -3M -4.11M | Net income 2018 | -30M -41.06M | EV / Sales 2017 * | - |
| Net cash position 2017 | 3.15M 4.31M | Net Debt 2018 | 12.9M 17.65M | EV / Sales 2018 | 56,975,119 x |
| P/E ratio 2017 * |
-
| P/E ratio 2018 |
-1.55
x | Employees | - |
| Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 89.48% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 36 | 19-11-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 36 | 19-11-26 |
Ravenquest Biomed Inc is a Canada-based diversified cannabis company. The Company is focused upon cannabis production, management services and consulting and specialized research & development. The Company integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions. It provides variety of services, such as Consulting, comprehensive cannabis consulting services; Training Solutions, training of operators, engineers, architects and installers; Solutions Implementation, project management, ongoing support; Design Studio Demonstration and training facility.
Sector
Business Support Services
| 1st Jan change | Capi. | |
|---|---|---|
| +7.33% | 7.48B | |
| -34.13% | 3.15B | |
| +5.88% | 2.66B | |
| +10.42% | 1.78B | |
| -8.71% | 1.09B | |
| +28.20% | 883M | |
| -9.09% | 717M | |
| -1.93% | 616M | |
| -8.20% | 550M |
